Eribulin regresses a doxorubicin-resistant Ewing's sarcoma with aFUS-ERGfusion andCDKN2A-deletion in a patient-derived orthotopic xenograft (PDOX) nude mouse model
2017 ◽
Vol 119
(1)
◽
pp. 967-972
◽
Keyword(s):
2019 ◽
Vol 83
(5)
◽
pp. 809-815
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2019 ◽
Vol 111
◽
pp. 835-840
◽
Keyword(s):
2020 ◽
Keyword(s):